Seegene Inc (096530)

Currency in KRW
34,300
-1,950(-5.38%)
Delayed Data·
Advertisement
Earnings results expected in 15 days
096530 is included in our AI-picked strategies. See how they work
Fair Value
Day's Range
33,00036,000
52 wk Range
21,70040,450
Key Statistics
Bid/Ask
34,300.00 / 34,400.00
Prev. Close
36,250
Open
36,000
Day's Range
33,000-36,000
52 wk Range
21,700-40,450
Volume
268.03K
Average Volume (3m)
320.59K
1-Year Change
33.0754%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
096530 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
48,000
Upside
+39.94%
Members' Sentiments
Bearish
Bullish
ProTips
Holds more cash than debt on its balance sheet

Seegene Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 48,000
(+39.94% Upside)

Earnings

Latest Release
14/08/2026
EPS / Forecast
-193.97 / 568.32
Revenue / Forecast
136B / 128.1B
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1,998
Dividend Yield
3.31%
Industry Median 0.50%
Annualised payout
1,200.00
Paid unevenly
5-Years Growth
+4.84%
Growth Streak

Seegene (096530) Income Statement & Profits

Compare 096530 to Peers and Sector

Metrics to compare
096530
Peers
Sector
Relationship
P/E Ratio
18.0x12.6x−0.3x
PEG Ratio
0.020.050.00
Price/Book
1.6x1.4x2.6x
Price / LTM Sales
3.2x2.6x2.9x
Upside (Analyst Target)
32.4%44.7%62.9%
Fair Value Upside
Unlock27.6%8.1%Unlock

Seegene, Inc. manufactures and sells molecular diagnostics products worldwide. It offers IVD products comprising respiratory disease detection products for respiratory infections; gastrointestinal disease detection products for gastrointestinal tract infections; human papillomavirus detection products; sexually transmitted infections causative pathogens detection products; tuberculosis detection products; drug resistance products; Magicplex sepsis real-time test for the detection and identification of sepsis causing pathogens; and meningitis detection products. The company also provides other products for the detection of SNPs in factor II, factor V, and MTHFR genes. The company has a collaboration with Werfen for the joint development of syndromic qPCR assays. Seegene, Inc. was founded in 2000 and is headquartered in Seoul, South Korea.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
3.14M6.89%119.30B
Other Institutional Investors
438.42K0.96%16.66B
Public Companies & Retail Investors
41.99M92.15%1.60T
Total
45.56M100.00%1.73T

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Vanguard Capital Management, LLC2.70%1,231,61146,801,218
BlackRock, Inc.1.68%766,68729,134,106

People Also Watch

24,150
086450
-2.03%
230,500
196170
-3.96%
372,000
128940
-1.98%
193,000
042700
-4.93%
28,200
214150
+0.18%

FAQ

What Is the Seegene (KOSDAQ: 096530) Share Price Today?

The Seegene stock price today is 34,300 KRW.

What Stock Exchange Does Seegene (096530) Trade On?

Seegene is listed and trades on the KOSDAQ.

What Is the Ticker (Stock Symbol) for Seegene?

The stock symbol (also called a 'ticker') for Seegene is "096530."

Does Seegene Pay Dividends? What’s The Current 096530 Dividend Yield?

Yes, 096530 Pays Dividends to its Shareholders. The current Seegene dividend yield is 3.3%%.

What Is the Current Seegene Market Capitalisation?

As of today, Seegene (KOSDAQ: 096530) market cap is 1.65T KRW.

What Is Seegene's (096530) Earnings Per Share (TTM)?

The Seegene EPS is currently 1,998 (Trailing Twelve Months).

When Is the Next Seegene Earnings Date?

Seegene's next earnings report will be released on 06/11/2026.

Is 096530 a Buy or Sell From a Technical Analyst Perspective?

Based on today's Seegene moving averages and other technical indicators, the daily buy/sell signal for 096530 stock is Sell.

How Many Times Has Seegene Stock Split?

Seegene has split 4 times. (See the 096530 stock split history page for full effective split date and price information.)

How Many Employees Does Seegene Have?

Seegene has 761 employees, based on their latest Companies House report.

What is the current trading status of Seegene (KOSDAQ: 096530)?

As of 22/10/2026, Seegene (096530) is trading at a share price of 34,300 KRW, with a previous close of 36,250 KRW. The stock has fluctuated within a day range of 33,000 KRW to 36,000 KRW, while its 52-week range spans from 21,700 KRW to 40,450 KRW.

What Is Seegene (096530) Price Target According to Analysts?

The average 12-month price target for Seegene is 48,000 KRW, with a high estimate of 52000 KRW and a low estimate of 44000 KRW. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +39.94% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.